We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$5.32B
AUM Growth
+$623M
Cap. Flow
+$473M
Cap. Flow %
8.88%
Top 10 Hldgs %
31.02%
Holding
1,563
New
308
Increased
332
Reduced
859
Closed
60

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$80.9M
2
MSFT icon
Microsoft
MSFT
+$63.9M
3
AMZN icon
Amazon
AMZN
+$61.8M
4
META icon
Meta Platforms (Facebook)
META
+$26.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.2M

Sector Composition

Rank Sector Weight
1 Real Estate 18.33%
2 Technology 16.44%
3 Consumer Discretionary 8.8%
4 Healthcare 7.69%
5 Communication Services 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTMX icon
1351
CytomX Therapeutics
CTMX
$701M
$18K ﹤0.01%
2,806
+366
+15% +$2.62K
NRIX icon
1352
Nurix Therapeutics
NRIX
$2.51B
$18K ﹤0.01%
+539
New +$17.9K
GGB icon
1353
Gerdau
GGB
$9.72B
$17K ﹤0.01%
4,537
-621
-12% -$2.07K
TECX
1354
Tectonic Therapeutic
TECX
$562M
$17K ﹤0.01%
100
+13
+15% +$2.31K
BCEL
1355
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$17K ﹤0.01%
+1,081
New +$16.2K
BRFS
1356
DELISTED
BRF SA
BRFS
$16K ﹤0.01%
3,912
+72
+2% +$269
ARDX icon
1357
Ardelyx
ARDX
$1.26B
$15K ﹤0.01%
2,334
-1,026
-31% -$6.09K
FPRX
1358
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$15K ﹤0.01%
+898
New +$11.3K
SINA
1359
DELISTED
Sina Corp
SINA
$15K ﹤0.01%
+349
New +$15K
RCEL icon
1360
Avita Medical
RCEL
$142M
$11K ﹤0.01%
+601
New +$13.2K
KSA icon
1361
iShares MSCI Saudi Arabia ETF
KSA
$622M
$10K ﹤0.01%
332
-628
-65% -$19.2K
TARO
1362
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$7K ﹤0.01%
+98
New +$6.3K
BPYU
1363
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$7K ﹤0.01%
484
-88
-15% -$1.34K
SCL icon
1364
Stepan Co
SCL
$1.32B
$5K ﹤0.01%
46
+2
+5% +$235
ARD
1365
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$3K ﹤0.01%
+158
New +$2.62K
ACLS icon
1366
Axcelis
ACLS
$3.69B
-5,175
Closed -$114K
ALSN icon
1367
Allison Transmission
ALSN
$10B
-22,510
Closed -$791K
ANDE icon
1368
Andersons Inc
ANDE
$2.49B
-40,412
Closed -$775K
ASMB icon
1369
Assembly Biosciences
ASMB
$507M
-69
Closed -$14K
AZZ icon
1370
AZZ Inc
AZZ
$4.41B
-6,173
Closed -$211K
CMTL icon
1371
Comtech Telecommunications
CMTL
$51.5M
-5,975
Closed -$84K
CNXN icon
1372
PC Connection
CNXN
$2.1B
-4,901
Closed -$201K
CORT icon
1373
Corcept Therapeutics
CORT
$10.1B
-18,327
Closed -$319K
CRBP icon
1374
Corbus Pharmaceuticals
CRBP
$168M
-117
Closed -$6K
DORM icon
1375
Dorman Products
DORM
$4.28B
-5,596
Closed -$506K

Similar funds

Pacer Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Pacer Advisors held 1,563 positions worth $5.32B, up 13% from $4.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pacer Advisors deployed $473M of net new capital in Q4 2020, opening 308 new positions and adding to 332 existing holdings. Its largest new stake was Chindata Group Holdings Limited American Depositary Shares: 1,166,530 shares worth $27.9M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $80.9M trimmed.

  • Pacer Advisors's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 1,166,530 shares worth $27.9M.
  • Pacer Advisors added most to Equinix in Q4 2020, an estimated $43.7M increase.
  • Pacer Advisors's biggest Q4 2020 reduction was Apple, cutting an estimated $80.9M.
  • Pacer Advisors fully exited INDUS Realty Trust, Inc. (MD) Common Stock in Q4 2020, selling an estimated $1.83M.
  • Pacer Advisors's ten largest holdings make up 31% of its $5.32B portfolio in Q4 2020.
  • Pacer Advisors opened 308 new positions and closed 60 in Q4 2020.
  • Pacer Advisors's portfolio value rose 13% quarter-over-quarter to $5.32B.

Based on Pacer Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.